Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
WSC 2022
ECTRIMS 2022
MS at the Limits 2022
EHDN 2022
MDS 2022
EEC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Bernhard Steinhoff
1:16
Insights from cenobamate studies
Bernhard Steinhoff
• 27 Jun 2022
1:11
Concomitant ASM dose reductions in clinical trial of adjunctive cenobamate for focal seizures
Bernhard Steinhoff
• 27 Jun 2022
1:18
The burden of epilepsy in different age groups
Bernhard Steinhoff
• 27 Jun 2022
1:04
An analysis of COVID-19 infection and vaccinations in epilepsy patients
Bernhard Steinhoff
• 27 Jun 2022
1:15
Discontinuation of anti-seizure medication in seizure-free epilepsy patients
Bernhard Steinhoff
• 27 Jun 2022
1:37
Cenobamate efficacy occurs early during titration
Bernhard Steinhoff
• 4 Jun 2021
2:08
The future of drug-resistant epilepsy management
Bernhard Steinhoff
• 4 Jun 2021
1:59
What is behind cenobamate’s remarkable efficacy against focal-onset seizures?
Bernhard Steinhoff
• 4 Jun 2021
1:53
Personalized treatment approaches in epilepsy
Bernhard Steinhoff
• 4 Jun 2021
